Cambridge Enterprise and Qkine Ltd sign deal to drive stem cell and regenerative medicine research

Cambridge Enterprise and specialist growth factor manufacturer Qkine Ltd sign key licensing deal for Activin A production technology

By |2018-04-18T11:46:33+00:00August 1st, 2017|news|Comments Off on Cambridge Enterprise and Qkine Ltd sign deal to drive stem cell and regenerative medicine research